Depatuxizumab Mafodotin
Catalog #: bp-50215
-
Overview
Depatuxizumab Mafodotin (Depatux-M, ABT-414) is an antibody-drug conjugate consisting of an EGFR IGg1 monoclonal antibody conjugated to the tubulin inhibitor monomethyl auristatin F (MMAF) via a stable maleimidocaproyl link. Depatuxizumab Mafodotin is used in the treatment of recurrent EGFR-amplified Glioblastoma (GBM). This product is for research use only.Product Details Species Reactivity Human Type Antibody-drug conjugate ADC antibody Depatuxizumab (anti-EGFR) ADC cytotoxin (drug) MMAF Immunogen Human EGFR DAR (Drug to Antibody Ratio) 3~4 Purity 98% Molecular Weight N/A Storage Condition Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. Storage Buffer 1xPBS -
Images
-
Datasheets and Documents